Company news
Enorama Pharma AB news in 2025
Enorama Pharma AB's news releases, calls and decks from 2025, newest first.
Bulletin from the extraordinary general meeting in Enorama Pharma AB (publ)
December 2, 2025
Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln
November 19, 2025
Enorama Pharma CEO Daniel Schröder Resigns
November 4, 2025
ERMA: Sharp revenue decline and deepening losses in H1 2025 amid US transition and PMTA focus
August 20, 2025
ERMA: Losses deepened as Enorama Pharma restructures for US white snus growth and seeks new funding
May 21, 2025
ERMA: Strong US snus growth offset by NRT write-down; urgent capital needs remain
February 19, 2025